Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director
|
MEDIZONE INTERNATIONAL INC (MZEI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/19/2020 |
15-15D
| Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]: |
05/11/2018 |
8-K
| Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits |
04/25/2018 |
RW
| Form RW - Registration Withdrawal Request: |
04/24/2018 |
8-K
| Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o... |
04/17/2018 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/13/2018 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
04/06/2018 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
04/03/2018 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
03/27/2018 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
03/22/2018 |
RW
| Form RW - Registration Withdrawal Request: |
03/20/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
02/12/2018 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
02/05/2018 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs:
|
"WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended ; B. Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a 8% convertible note of the Company, in the form attached hereto as Exhibit A , in the aggregate principal amount of US$152,500.00 issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the “Note”), convertible into shares of common stock, $0.001 par value per share, of the Company , upon the terms...",
"Securities Purchase Agreement, by and between the Company and SBI Investments LLC, 2014-1",
"Convertible Promissory Note, made by the Company in favor of L2 Capital, LLC",
"Convertible Promissory Note, made by the Company in favor of SBI Investments LLC, 2014-1",
"Common Stock Purchase Warrant, by and between the Company and L2 Capital LLC",
"Common Stock Purchase Warrant, by and between the Company and SBI Investments LLC, 2014-1",
"Equity Purchase Agreement, by and between the Company and the Investors",
"Registration Rights Agreement, by and between the Company and the Investors",
"Trading Agreement, by and between L2 Capital LLC and SBI Investments LLC, 2014-1",
"Medizone Announces Completion of Financing Kalamazoo, Michigan, January 31, 2018. Medizone International, Inc." |
|
02/01/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/05/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
11/08/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
11/03/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/16/2017 |
8-K
| Quarterly results |
09/19/2017 |
8-K
| Quarterly results |
08/28/2017 |
8-K
| Quarterly results |
08/24/2017 |
8-K
| Quarterly results |
08/08/2017 |
10-Q
| Quarterly Report for the period ended June 30, 2017 |
06/22/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/08/2017 |
8-K
| Form 8-K - Current report |
05/31/2017 |
8-K
| Form 8-K - Current report |
05/23/2017 |
8-K
| Form 8-K - Current report |
05/12/2017 |
10-Q
| Quarterly Report for the period ended March 31, 2017 |
04/25/2017 |
8-K
| Form 8-K - Current report |
04/07/2017 |
8-K
| Form 8-K - Current report |
04/06/2017 |
8-K
| Form 8-K - Current report |
03/22/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
03/03/2017 |
8-K
| Form 8-K - Current report |
03/01/2017 |
8-K
| Form 8-K - Current report |
02/28/2017 |
8-K
| Form 8-K - Current report |
|
|
|